| Code | 0702C | ||||||||||
| MA number | 30/0149/16-S | ||||||||||
| Product Form: | tbl flm 100x100 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 30 - ANTIDEPRESSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 17.08.2016 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Sertraline Accord tbl flm_07.2025.pdf
|
| SPC: |
SPC_Sertraline Accord tbl flm_07.2025.pdf
|
| Safety feature | Yes |
| Data update: | 08.01.2024 |
